Labcorp Holdings Inc. logo
Labcorp Holdings Inc. (LH)
Compare

Labcorp Holdings Inc. (LH) Earnings Yield: 4.24%

Is Labcorp Holdings Inc.’s earnings yield high or low?

Labcorp Holdings Inc.'s earnings yield of 4.24% is 30% below its 5-year average of 6.05%, near the low end of its 5-year range (2.06%–12.55%).

As of Sunday, June 14, 2026. 14.21% above its 12-month average of 3.71%.

LH Earnings Yield Chart

LH Earnings Yield
4.24%+28.10% 1Y
Zoom

LH Average Earnings Yield Chart

LH Current vs Average Earnings Yield Chart

LH Earnings Yield Metrics

EARNINGS YIELD

4.24%

EARNINGS YIELD AVG TTM

3.71%

EARNINGS YIELD AVG 3Y

3.34%

EARNINGS YIELD AVG 5Y

6.05%

EARNINGS YIELD AVG 10Y

6.10%

EARNINGS YIELD AVG 15Y

6.24%

EARNINGS YIELD AVG 20Y

6.36%

CURRENT VS TTM AVG

+14.21%

CURRENT VS 3Y AVG

+26.81%

CURRENT VS 5Y AVG

-29.96%

CURRENT VS 10Y AVG

-30.52%

CURRENT VS 15Y AVG

-32.05%

CURRENT VS 20Y AVG

-33.33%

LH Competitors' Earnings Yield

NAMEMARKET CAPEARNINGS YIELDTTM3Y5Y
Labcorp Holdings Inc. (LH)$21.83B4.24%3.71%3.34%6.05%
Mettler-Toledo International Inc. (MTD)$22.86B3.78%3.16%3.10%2.84%
BioNTech SE (BNTX)$22.90BN/A8.30%19.01%16.60%
United Therapeutics Corporation (UTHR)$23.17B4.96%6.10%6.92%6.45%
Waters Corporation (WAT)$23.17B2.21%3.20%3.31%3.36%
Moderna, Inc. (MRNA)$19.80BN/A10.37%11.47%11.47%
Veeva Systems Inc. (VEEV)$25.92B3.52%2.30%1.92%1.65%
Hologic, Inc. (HOLX)$16.97B3.16%3.63%3.48%5.61%
DexCom, Inc. (DXCM)$29.08B3.10%2.58%1.81%1.32%
Biogen Inc. (BIIB)$29.53B4.67%6.28%5.94%5.80%

Earnings Yield vs P/E Ratio

Earnings Yield

4.24%

EPS ÷ Price

P/E Ratio

23.6

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

  • It expresses earnings relative to share price as a percentage
  • It can be compared with FCF yield and dividend yield
  • It can be compared with bond yields because both are percentages
  • It is mathematically the inverse of the P/E ratio

Labcorp Holdings Inc. Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Labcorp Holdings Inc. Earnings Yield FAQ

What is the earnings yield for Labcorp Holdings Inc. (LH)?
The earnings yield for LH stock is 4.24%.
Is Labcorp Holdings Inc.'s earnings yield high or low?
Labcorp Holdings Inc.'s earnings yield of 4.24% is 30% below its 5-year average of 6.05%, near the low end of its 5-year range (2.06%–12.55%).
What is the TTM average earnings yield for Labcorp Holdings Inc. (LH)?
The TTM average earnings yield for LH stock is 3.71%.
What is the 3Y average earnings yield for Labcorp Holdings Inc. (LH)?
The 3Y average earnings yield for LH stock is 3.34%.
What is the 5Y average earnings yield for Labcorp Holdings Inc. (LH)?
The 5Y average earnings yield for LH stock is 6.05%.
What is the 10Y average earnings yield for Labcorp Holdings Inc. (LH)?
The 10Y average earnings yield for LH stock is 6.10%.
What is the 15Y average earnings yield for Labcorp Holdings Inc. (LH)?
The 15Y average earnings yield for LH stock is 6.24%.
What is the 20Y average earnings yield for Labcorp Holdings Inc. (LH)?
The 20Y average earnings yield for LH stock is 6.36%.

Labcorp Holdings Inc. Earnings Yield History

DATEEARNINGS YIELD
2026-06-124.24%
2026-06-114.26%
2026-06-104.20%
2026-06-094.16%
2026-06-084.31%
2026-06-054.26%
2026-06-044.33%
2026-06-034.36%
2026-06-024.38%
2026-06-014.40%
2026-05-294.34%
2026-05-284.30%
2026-05-274.37%
2026-05-264.37%
2026-05-224.34%
2026-05-214.42%
2026-05-204.39%
2026-05-194.45%
2026-05-184.42%
2026-05-154.51%
2026-05-144.44%
2026-05-134.44%
2026-05-124.39%
2026-05-114.43%
2026-05-084.44%
2026-05-074.37%
2026-05-064.39%
2026-05-054.39%
2026-05-044.46%
2026-05-014.09%
2026-04-304.07%
2026-04-294.07%
2026-04-284.03%
2026-04-273.97%
2026-04-243.97%
2026-04-233.95%
2026-04-223.84%
2026-04-213.83%
2026-04-203.89%
2026-04-173.86%
2026-04-163.93%
2026-04-153.92%
2026-04-143.89%
2026-04-133.96%
2026-04-104.01%
2026-04-093.83%
2026-04-083.81%
2026-04-073.89%
2026-04-063.81%
2026-04-023.82%
2026-04-013.84%
2026-03-313.92%
2026-03-303.97%
2026-03-273.96%
2026-03-263.90%
2026-03-253.93%
2026-03-243.93%
2026-03-233.96%
2026-03-203.98%
2026-03-193.96%
2026-03-183.94%
2026-03-173.87%
2026-03-163.92%
2026-03-133.97%
2026-03-123.98%
2026-03-113.87%
2026-03-103.89%
2026-03-093.82%
2026-03-063.88%
2026-03-053.79%
2026-03-043.72%
2026-03-033.70%
2026-03-023.65%
2026-02-273.62%
2026-02-263.64%
2026-02-253.70%
2026-02-243.64%
2026-02-233.57%
2026-02-203.60%
2026-02-193.60%
2026-02-183.65%
2026-02-173.68%
2026-02-133.60%
2026-02-123.66%
2026-02-113.51%
2026-02-103.58%
2026-02-093.71%
2026-02-063.67%
2026-02-053.66%
2026-02-043.69%
2026-02-033.74%
2026-02-023.77%
2026-01-303.75%
2026-01-293.77%
2026-01-283.80%
2026-01-273.76%
2026-01-263.81%
2026-01-233.82%
2026-01-223.77%
2026-01-213.78%
2026-01-203.75%
2026-01-163.76%
2026-01-153.79%
2026-01-143.89%
2026-01-134.01%
2026-01-124.07%
2026-01-094.04%
2026-01-084.00%
2026-01-074.01%
2026-01-063.91%
2026-01-054.02%
2026-01-024.05%
2025-12-314.06%
2025-12-304.02%
2025-12-294.02%
2025-12-264.01%
2025-12-244.00%
2025-12-234.02%
2025-12-223.99%
2025-12-194.04%
2025-12-184.04%
2025-12-173.98%
2025-12-163.94%
2025-12-153.87%
2025-12-123.85%
2025-12-113.85%
2025-12-103.89%
2025-12-093.94%
2025-12-083.92%
2025-12-053.94%
2025-12-043.89%
2025-12-033.83%
2025-12-023.83%
2025-12-013.80%
2025-11-283.79%
2025-11-263.80%
2025-11-253.77%
2025-11-243.84%
2025-11-213.83%
2025-11-203.89%
2025-11-193.91%
2025-11-183.92%
2025-11-173.90%
2025-11-143.81%
2025-11-133.80%
2025-11-123.83%
2025-11-113.80%
2025-11-103.90%
2025-11-074.03%
2025-11-064.13%
2025-11-054.06%
2025-11-044.03%
2025-11-033.95%
2025-10-314.01%
2025-10-303.59%
2025-10-293.65%
2025-10-283.49%
2025-10-273.29%
2025-10-243.25%
2025-10-233.19%
2025-10-223.21%
2025-10-213.19%
2025-10-203.12%
2025-10-173.17%
2025-10-163.20%
2025-10-153.21%
2025-10-143.24%
2025-10-133.28%
2025-10-103.26%
2025-10-093.26%
2025-10-083.27%
2025-10-073.24%
2025-10-063.30%
2025-10-033.28%
2025-10-023.25%
2025-10-013.25%
2025-09-303.16%
2025-09-293.21%
2025-09-263.23%
2025-09-253.28%
2025-09-243.25%
2025-09-233.24%
2025-09-223.25%
2025-09-193.27%
2025-09-183.27%
2025-09-173.29%
2025-09-163.31%
2025-09-153.29%
2025-09-123.26%
2025-09-113.24%
2025-09-103.32%
2025-09-093.26%
2025-09-083.27%
2025-09-053.26%
2025-09-043.29%
2025-09-033.31%
2025-09-023.31%
2025-08-293.26%
2025-08-283.29%
2025-08-273.25%
2025-08-263.26%
2025-08-253.29%
2025-08-223.26%
2025-08-213.28%
2025-08-203.26%
2025-08-193.29%
2025-08-183.35%
2025-08-153.35%
2025-08-143.34%
2025-08-133.33%
2025-08-123.37%
2025-08-113.39%
2025-08-083.41%
2025-08-073.49%
2025-08-063.48%
2025-08-053.44%
2025-08-043.44%
2025-08-013.47%
2025-07-313.33%
2025-07-303.29%
2025-07-293.31%
2025-07-283.31%
2025-07-253.27%
2025-07-243.24%
2025-07-233.46%
2025-07-223.44%
2025-07-213.57%
2025-07-183.56%
2025-07-173.51%
2025-07-163.52%
2025-07-153.53%
2025-07-143.47%
2025-07-113.47%
2025-07-103.42%
2025-07-093.35%
2025-07-083.37%
2025-07-073.36%
2025-07-033.31%
2025-07-023.33%
2025-07-013.28%
2025-06-303.30%
2025-06-273.33%
2025-06-263.37%
2025-06-253.35%
2025-06-243.30%
2025-06-233.32%
2025-06-203.31%
2025-06-183.32%
2025-06-173.34%
2025-06-163.28%
2025-06-133.32%
2025-06-123.31%
2025-06-113.34%
2025-06-103.34%
2025-06-093.39%
2025-06-063.41%
2025-06-053.44%
2025-06-043.41%
2025-06-033.46%
2025-06-023.50%

Showing the most recent 260 of 5,033 data points. The chart above shows the full history.

About Labcorp Holdings Inc.

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Burlington, NC
60,900 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Adam H. Schechter